- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 10.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 4.82M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$488.29K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.22M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.03M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$19.23K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.46M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.16M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.47M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.8M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.14M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.16 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.35M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $801.14K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $153.48K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $136.83K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.17M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$764.58K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.44M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$772.18K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $62.88K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $165.8K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $290.49K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $388.03K |
| Revenue | Q1 2026 · Mar 31, 2026 | $353.38K |
| Revenue | Q1 2026 · Mar 31, 2025 | $553.82K |